Search

Your search keyword '"Deepu, A"' showing total 276 results

Search Constraints

Start Over You searched for: Author "Deepu, A" Remove constraint Author: "Deepu, A" Topic medicine.medical_specialty Remove constraint Topic: medicine.medical_specialty
276 results on '"Deepu, A"'

Search Results

1. Phenytoin-induced organising pneumonia: An unknown entity

2. Optimal Supportive Care With Selinexor Improves Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

3. Multidrug-resistant tuberculosis in COVID-19: Double trouble

4. Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma

5. Chimeric Antigen Receptor T-Cell Therapeutics for Multiple Myeloma

6. Evaluation of Pulmonary Hypoplasia in Various Congenital Anomalies with a Comparison of Two Conventional Methods of Assessment: Radial Alveolar Count (RAC) and Lung Weight: Body Weight Ratio (LBW)

7. Histopathological spectrum of salivary gland lesions in rural India

8. Clinico-etiological characteristics of organizing pneumonia: A retrospective study

9. MET Exon 14–altered Lung Cancers and MET Inhibitor Resistance

10. Refractory Kawasaki Disease—a Challenge for the Pediatrician

11. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumab

13. Prescription of near addition and its relation to accommodative reserve in presbyopia - The dichotomy between theory and practice

14. Transcatheter Aortic Valve Replacement With the LOTUS Edge System

15. Invasive carcinoma no special type, pleomorphic carcinoma: Case report of a rare variant of invasive breast carcinoma

16. Results from the 2019 American Society of Cytopathology survey on rapid onsite evaluation (ROSE)–part 2: subjective views among the cytopathology community

17. Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma

18. Self-expanding metal stent in esophageal perforations and anastomotic leaks

19. An inflammatory cytokine signature predicts COVID-19 severity and survival

20. Improving exclusive breast feeding in the first 24 h of life using Plan-Do-Study-Act cycle in a tertiary care hospital

21. Unsuspecting Dietary Factors in Hyperkalemia: A Case Report on Why History Matters

22. Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients

23. SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas

24. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

25. Pan‐Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6 – NTRK3 fusion

26. Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach

27. Pulmonary Thromboembolism Post-COVID Convalescent Plasma Therapy: Adding Fuel to A Smoldering Fire!

28. Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications

29. INCIDENCE, MITIGATION, AND MANAGEMENT OF NEUROLOGIC ADVERSE EVENTS IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) IN CARTITUDE-2

30. EFFICACY AND SAFETY OF CILTACABTAGENE AUTOLEUCEL (CILTA-CEL), A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA (MM) AFTER 1–3 PRIOR LINES OF THERAPY: CARTITUDE-2 PHASE 2 STUDY

31. Spindle Cell Carcinoma (Sarcomatoid) of Colon Presenting as Weight Loss

33. Treatment Bridging With a 28-Day Metronomic Therapy (Metro-28) for Relapsed Refractory Multiple Myeloma

34. Prevalence of Risk Factors for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Patients With Cryptogenic Cirrhosis

35. Patient Expectations and Perceptions of Treatment in CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma

36. Caverno-Chest wall sinus: A rare manifestation of chest tuberculosis

37. Results from the 2019 American Society of Cytopathology survey on rapid on-site evaluation—Part 1: objective practice patterns

38. Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations

39. Evaluation of spectrum of cervical lesions by PAP smear in rural medical college

40. PET-Computed Tomography in Myeloma

41. Displaced Cartilage Within Lymph Node Parenchyma Is a Novel Biopsy Site Change in Resected Mediastinal Lymph Nodes Following EBUS-TBNA

42. Health system resilience: Ensuring TB services during COVID-19 pandemic in Kerala, India

43. Cardiac surgery in obese patients

44. Bispecific Antibodies in Multiple Myeloma: Present and Future

45. P-155: Incidence, mitigation, and management of neurologic adverse events in CARTITUDE-2, a phase 2 study of ciltacabtagene autoleucel (cilta-cel) in patients with Multiple Myeloma

46. OAB-024: Updated results from CARTITUDE-1: Ciltacabtagene autoleucel, a B-cell maturation antigen–directed chimeric antigen receptor T (CAR-T) cell therapy, in relapsed/refractory multiple myeloma (RRMM)

47. MM-119: Updated Results of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM)

48. MM-112: Incidence, Mitigation, and Management of Neurologic Adverse Events in the CARTITUDE-2 Study of Patients with Multiple Myeloma Treated with Ciltacabtagene Autoleucel (Cilta-Cel)

49. Acute coronary syndrome with separate right sinus origin of all three coronary arteries: diagnosis and successful left anterior descending percutaneous coronary intervention

50. Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Catalog

Books, media, physical & digital resources